Related Experiment Videos
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction
Taro Kawai1, Ken Takahashi, Shintaro Sato
1Exploratory Research for Advanced Technology, Japan Science and Technology Agency.
Nature Immunology
|August 30, 2005
Summary
Interferon-beta promoter stimulator 1 (IPS-1) is a novel molecule that activates type I interferon production. This discovery is key for understanding RIG-I and Mda5-mediated antiviral immune responses.
Area of Science:
- Immunology
- Molecular Biology
- Virology
Background:
- Type I interferons are crucial for the innate immune system's defense against viral infections.
- Identifying key signaling molecules in interferon induction pathways is essential for understanding antiviral immunity.
Purpose of the Study:
- To identify novel molecules that induce type I interferon production.
- To elucidate the role of the identified molecule in antiviral immune responses.
Main Methods:
- High-throughput functional screening of interferon inducers.
- Overexpression studies of the identified molecule (IPS-1).
- Analysis of transcription factor activation (IRF3, IRF7, NF-kappaB).
- Investigating the role of protein kinases (TBK1, IKKi).
- Assessing protein-protein interactions using CARD domains.
- RNA interference (RNAi) to 'knockdown' IPS-1 expression.
Main Results:
- A novel molecule, interferon-beta promoter stimulator 1 (IPS-1), was identified.
- IPS-1 overexpression induced type I interferon and interferon-inducible genes.
- IPS-1 activated IRF3, IRF7, and NF-kappaB transcription factors, requiring TBK1 and IKKi.
- IPS-1 interacts with RIG-I and Mda5 via its N-terminal CARD-like structure.
- Knockdown of IPS-1 inhibited virus-induced interferon production.
Conclusions:
- IPS-1 is a critical adaptor protein in the RIG-I and Mda5-mediated antiviral immune pathways.
- IPS-1 plays a significant role in initiating type I interferon responses upon viral detection.